drugset / Trial / NCT01496677

Pharmacokinetics, Safety, and Tolerability of TR-701 Free Acid (FA) in Elderly Subjects

NCT01496677

Phase 1 Completed 28 enrolled Merck & Co., Inc.
RandomizedParallel-groupOpen-labelOther

Summary

To compare the pharmacokinetic (PK) profile of TR-700 in elderly subjects versus younger control subjects

Timeline

Start
2012-01-17
Primary completion
2012-02-28
Completion
2012-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Tedizolid Small molecule 200 mg Oral

Indications

No indication recorded.